The use of prostate specific antigen (PSA) density in detecting prostate cancer in Chinese men with PSA levels of 4–10 ng/mL

Xiangyi Zheng(Tianjin University), Zhao-Dian Chen, Liping Xie(First Affiliated Hospital Zhejiang University), Kai Yang(Harbin Medical University), Jie Qin(Shanghai Medical College of Fudan University), Wei Ding(First Affiliated Hospital Zhejiang University), Yu Bai(First Affiliated Hospital Zhejiang University), Huafeng Shen(First Affiliated Hospital Zhejiang University), Yuyong Wang(First Affiliated Hospital Zhejiang University)
Journal of Cancer Research and Clinical Oncology
April 29, 2008
10.1007/s00432-008-0400-8
Cited by 37

Related Papers

The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
|Molecular Cancer|2020|383
Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis
|World Journal of Surgical Oncology|2019|276
Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels
|Oncotarget|2017|207
Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells <i>in vitro</i> and inhibits tumor growth <i>in vivo</i>
|Cancer Science|2009|188